The key arguments and implications surrounding the Supreme Court case involving mifepristone and medication abortion are multifaceted. 1. **Access to Medication Abortion**: The FDA’s regulatory changes have made medication abortion more accessible by allowing the use of mifepristone up to 10 weeks into pregnancy and permitting mail delivery without an in-person clinician visit. Proponents argue […]